—
C+
C+ The full Closelook — membership. Open the C+ overview

Ypsomed Holding AG (YPSN.SW) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Ypsomed Holding AG

YPSN.SW in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Ypsomed designs, builds and sells injection and infusion devices that let patients manage their own medication, including pen injectors, auto-injectors, wearable injectors and contract-made infusion sets and reservoirs. It sells through subsidiaries and distributors to hospitals, doctors, pharmacies and patients across Switzerland, Europe, North America and beyond. The company is based in Burgdorf, Switzerland.
Where it sits in the stack
Ypsomed carries no seat in our index; it sits in our universe under Healthcare, in the medical instruments and supplies sleeve, as a maker of self-injection hardware rather than an AI-stack name.
Who it is priced against
The diary has no peer group recorded for Ypsomed; the market sometimes names Becton Dickinson as a comparable maker of injection devices.
Why Closelook tracks it
It holds no index seat and carries no Closelook score; the diary's only current record is the chart reading, so coverage stays limited to price behaviour for now.
What the diary watches
The diary watches whether the shares hold above their 200-day average after slipping under the 50-day line and losing ground from the 52-week high.

Ypsomed Holding AG (YPSN.SW) trades on the SW exchange in Switzerland, classified under Healthcare.

The Closelook company score reads 55/100 composite (momentum 63, quality 62, valuation 30) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for YPSN.SW, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Medical Instruments & Supplies · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies

Names in the same industry from the Closelook universe; scored names rank on their Closelook score, the rest on trend state.

Compared against YPSN.SW on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 1.28%, annual · buybacks 151 m CHF in FY2026

Dividends and capital return

What YPSN.SW pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 4.40 CHF per share · a 1.28% yield on the 2026-09-18 close 1 distribution, paid once a year 2026-09-18
  • Change on the year +100.0% against the prior twelve months prior twelve months 2.20 CHF per share
  • Last distribution 4.40 CHF per share as the price series records it, within days of the ex-date 2026-07-03
  • By calendar year 2025: 2.20 CHF (partial) · 2026: 4.40 CHF to date first distribution recorded in the three-year window: 2025-07-04
  • Dividends paid, FY2026 30 m CHF 43% of earnings
  • Buybacks, FY2026 151 m CHF 3.3% of today's market value
  • Share count −0.3% in FY2026
  • Capital returned 181 m CHF in a year of negative free cash flow dividends and buybacks together

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sector × region Health care in Europe: +3.0% week · −4.5% month · −2.1% quarter · −5.0% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-20
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is Ypsomed Holding AG (YPSN.SW)?

Ypsomed Holding AG trades as YPSN.SW on the SW exchange (Switzerland) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-19.

Is YPSN.SW in a Closelook index?

Not currently — Ypsomed Holding AG is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

What is Ypsomed Holding AG's Closelook composite score?

55 out of 100, with momentum 63, quality 62 and valuation 30 sub-scores, as of 2026-09-19. Scores are Closelook's own research readings, not ratings or investment advice.

Where does YPSN.SW trade against its moving averages?

Pullback inside an uptrend stack: Trades -11.2% vs the 50-day and +4.8% vs the 200-day average, 17.5% below the 52-week high and +34.1% off the 52-week low; a golden cross printed 62 sessions ago. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Ypsomed Holding AG do?

Ypsomed designs, builds and sells injection and infusion devices that let patients manage their own medication, including pen injectors, auto-injectors, wearable injectors and contract-made infusion sets and reservoirs. It sells through subsidiaries and distributors to hospitals, doctors, pharmacies and patients across Switzerland, Europe, North America and beyond. The company is based in Burgdorf, Switzerland. The diary has no peer group recorded for Ypsomed; the market sometimes names Becton Dickinson as a comparable maker of injection devices.

Where does Ypsomed Holding AG sit in the AI build-out?

Ypsomed carries no seat in our index; it sits in our universe under Healthcare, in the medical instruments and supplies sleeve, as a maker of self-injection hardware rather than an AI-stack name. It holds no index seat and carries no Closelook score; the diary's only current record is the chart reading, so coverage stays limited to price behaviour for now.

Does Ypsomed Holding AG pay a dividend?

Ypsomed Holding AG has paid 4.40 CHF per share over the last twelve months, paid once a year, a trailing yield of 1.28% on the 2026-09-18 close; the last distribution recorded in the price series was 4.40 CHF on 2026-07-03. In fiscal 2026 the company paid 30 m CHF in dividends and bought back 151 m CHF of its own shares. The share count fell 0.3% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for YPSN.SW, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Medical Instruments & Supplies. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.